NO20032006L - Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser - Google Patents

Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser

Info

Publication number
NO20032006L
NO20032006L NO20032006A NO20032006A NO20032006L NO 20032006 L NO20032006 L NO 20032006L NO 20032006 A NO20032006 A NO 20032006A NO 20032006 A NO20032006 A NO 20032006A NO 20032006 L NO20032006 L NO 20032006L
Authority
NO
Norway
Prior art keywords
melagatran
medicament
manufacture
treatment
ischemic disorders
Prior art date
Application number
NO20032006A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032006D0 (no
Inventor
David Gustafsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20032006D0 publication Critical patent/NO20032006D0/no
Publication of NO20032006L publication Critical patent/NO20032006L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20032006A 2000-11-06 2003-05-05 Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser NO20032006L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/705,912 US6462021B1 (en) 2000-11-06 2000-11-06 Use of low molecular weight thrombin inhibitor
PCT/SE2000/002204 WO2002036157A1 (en) 2000-11-06 2000-11-09 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders

Publications (2)

Publication Number Publication Date
NO20032006D0 NO20032006D0 (no) 2003-05-05
NO20032006L true NO20032006L (no) 2003-07-01

Family

ID=24835453

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032006A NO20032006L (no) 2000-11-06 2003-05-05 Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser

Country Status (14)

Country Link
US (1) US6462021B1 (xx)
EP (1) EP1333855A1 (xx)
JP (2) JP2004512376A (xx)
KR (1) KR20040004431A (xx)
CN (1) CN1455679A (xx)
AU (2) AU2562501A (xx)
BR (1) BR0017367A (xx)
CA (1) CA2428012A1 (xx)
IL (1) IL155431A0 (xx)
MX (1) MXPA03003980A (xx)
NO (1) NO20032006L (xx)
NZ (1) NZ525487A (xx)
WO (1) WO2002036157A1 (xx)
ZA (1) ZA200303013B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
SE0201374D0 (sv) * 2002-05-06 2002-05-06 Astrazeneca Ab Pharmaceutical combination
SE0201373D0 (sv) * 2002-05-06 2002-05-06 Astrazeneca Ab Combination therapy
US20050288253A1 (en) 2002-09-09 2005-12-29 Trigen Limited Boronic acid salts
MXPA05002662A (es) 2002-09-09 2005-09-20 Trigen Ltd Sales de metal multivalente de acidos boronicos para el tratamiento de trombosis.
GB0306615D0 (en) * 2003-03-22 2003-04-30 Astrazeneca Ab New use
BRPI0715492A2 (pt) * 2006-07-17 2013-03-19 Boehringer Ingelheim Int uso de inibidores diretos de trombina

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE504185C2 (sv) 1994-11-08 1996-12-02 Astra Ab Lagringsstabil vattenlösning för infusion av trombininhibitorer
SE9404196D0 (sv) 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
ES2186807T3 (es) 1995-10-24 2003-05-16 Merck & Co Inc Inhibidores de trombina.
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9601556D0 (sv) 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9602145D0 (sv) 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism
SE9603724D0 (sv) 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
SE9704401D0 (sv) 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
SE9704400D0 (sv) 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (sv) 1999-01-13 1999-01-13 Astra Ab New use
AR023510A1 (es) * 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.

Also Published As

Publication number Publication date
NO20032006D0 (no) 2003-05-05
ZA200303013B (en) 2004-07-16
IL155431A0 (en) 2003-11-23
MXPA03003980A (es) 2003-08-19
EP1333855A1 (en) 2003-08-13
BR0017367A (pt) 2003-10-07
US6462021B1 (en) 2002-10-08
KR20040004431A (ko) 2004-01-13
AU2001225625B2 (en) 2006-06-15
CA2428012A1 (en) 2002-05-10
JP2005120098A (ja) 2005-05-12
AU2562501A (en) 2002-05-15
NZ525487A (en) 2004-11-26
JP2004512376A (ja) 2004-04-22
CN1455679A (zh) 2003-11-12
WO2002036157A1 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
IL196301A0 (en) Medicament for the treatment of hapatitis c
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
EE200300363A (et) N-(püridinüül)-1H-indool-1-amiinühendite kasutamine ravimi valmistamiseks, mis on ette nähtud müeliinikaotusega seotud haiguste ja seisundite ravimiseks
DK1443938T3 (da) Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20012976L (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
ITMI20001827A0 (it) Medicamento antinfiammatorio
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20020784L (no) Medikament for behandling av brudd
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application